241 filings
Page 2 of 13
8-K
e92vxq
19 Jul 22
Departure of Directors or Certain Officers
7:33pm
8-K
9as sbx2hbxgtpudx
6 Jun 22
Departure of Directors or Certain Officers
5:27pm
8-K
yg3bfhf
10 May 22
Arrowhead Pharmaceuticals Reports Fiscal 2022 Second Quarter Results
4:06pm
8-K
wdr7ct82
5 May 22
Departure of Directors or Certain Officers
2:26pm
8-K
ll4uy9 py0
25 Apr 22
Arrowhead Pharmaceuticals and Vivo Capital Launch Joint Venture Aimed at Greater China Market
7:31am
8-K
youypdphv 0909y
18 Mar 22
Submission of Matters to a Vote of Security Holders
4:49pm
8-K
2kse92 m6zw4
2 Feb 22
Arrowhead Pharmaceuticals Reports Fiscal 2022 First Quarter Results
4:05pm
8-K
d3n3s3k
20 Dec 21
Arrowhead Initiates Project to Build New Manufacturing and Lab Facilities
8:02am
8-K
lxq4c ir0
16 Dec 21
In the Court of Chancery of the State of Delaware
6:08am
8-K
2pxik uh0o7wx
22 Nov 21
Arrowhead Pharmaceuticals Reports Fiscal 2021 Year End Results
4:05pm
8-K
glvice8 roaz56tftu
27 Aug 21
Departure of Directors or Certain Officers
12:00am
8-K
svdyj6b0r
5 Aug 21
Arrowhead Pharmaceuticals Reports Fiscal 2021 Third Quarter Results
4:06pm
8-K
872ns1rsvvk7igcb8
22 Jun 21
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
4:09pm
8-K
ekim1vphf9 ugrtj
16 Jun 21
Other Events
4:05pm
8-K
nt7r96179
4 May 21
Arrowhead Pharmaceuticals Reports Fiscal 2021 Second Quarter Results
4:05pm
8-K
obep uhubj
24 Mar 21
Departure of Directors or Certain Officers
5:15pm
8-K
4rsaduih49jo t1
4 Feb 21
Arrowhead Pharmaceuticals Reports Fiscal 2021 First Quarter Results
4:05pm
8-K
pveuz6
23 Nov 20
Arrowhead Pharmaceuticals Reports Fiscal 2020 Year End Results
4:05pm
8-K
02akkr 9ukit0
9 Oct 20
Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
5:00pm
8-K
nsflysvc7jk8ezyg0a6
8 Sep 20
Departure of Directors or Certain Officers
7:35am